114200-31-6,MFCD27991290
Catalog No.:AA01ENKC

114200-31-6 | (3R)-2-Oxo-3-[[(2S)-2-Pyrrolidinylcarbonyl]amino]-1-pyrrolidineacetamide

This product is typically in stock,please click "Inquire" below or
contact us at [email protected] for pricing and availability information.
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01ENKC
Chemical Name:
(3R)-2-Oxo-3-[[(2S)-2-Pyrrolidinylcarbonyl]amino]-1-pyrrolidineacetamide
CAS Number:
114200-31-6
Molecular Formula:
C11H18N4O3
Molecular Weight:
254.2856
MDL Number:
MFCD27991290
SMILES:
NC(=O)CN1CC[C@H](C1=O)NC(=O)[C@@H]1CCCN1
Properties
Computed Properties
 
Complexity:
371  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-1.7  

Literature

Title: PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: implications for the treatment of negative symptoms in schizophrenia.

Journal: Schizophrenia research 20110101

Title: Design and synthesis of photoaffinity-labeling ligands of the L-prolyl-L-leucylglycinamide binding site involved in the allosteric modulation of the dopamine receptor.

Journal: Journal of medicinal chemistry 20060112

Title: Iso-lactam and reduced amide analogues of the peptidomimetic dopamine receptor modulator 3(R)-[(2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide.

Journal: Bioorganic & medicinal chemistry 20030901

Title: Synthesis and dopamine receptor modulating activity of 3-substituted gamma-lactam peptidomimetics of L-prolyl-L-leucyl-glycinamide.

Journal: Journal of medicinal chemistry 20030227

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:114200-31-6 Molecular Formula|114200-31-6 MDL|114200-31-6 SMILES|114200-31-6 (3R)-2-Oxo-3-[[(2S)-2-Pyrrolidinylcarbonyl]amino]-1-pyrrolidineacetamide
Catalog No.: AA01ENKC
114200-31-6,MFCD27991290
114200-31-6 | (3R)-2-Oxo-3-[[(2S)-2-Pyrrolidinylcarbonyl]amino]-1-pyrrolidineacetamide
This product is typically in stock,please click "Inquire" below or contact us at [email protected]for pricing and availability information.
Inquire
Technical Information
Catalog Number: AA01ENKC
Chemical Name: (3R)-2-Oxo-3-[[(2S)-2-Pyrrolidinylcarbonyl]amino]-1-pyrrolidineacetamide
CAS Number: 114200-31-6
Molecular Formula: C11H18N4O3
Molecular Weight: 254.2856
MDL Number: MFCD27991290
SMILES: NC(=O)CN1CC[C@H](C1=O)NC(=O)[C@@H]1CCCN1
Properties
Complexity: 371  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 2  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 3  
Isotope Atom Count: 0  
Rotatable Bond Count: 4  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -1.7  
Literature fold

Title: PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: implications for the treatment of negative symptoms in schizophrenia.

Journal: Schizophrenia research20110101

Title: Design and synthesis of photoaffinity-labeling ligands of the L-prolyl-L-leucylglycinamide binding site involved in the allosteric modulation of the dopamine receptor.

Journal: Journal of medicinal chemistry20060112

Title: Iso-lactam and reduced amide analogues of the peptidomimetic dopamine receptor modulator 3(R)-[(2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide.

Journal: Bioorganic & medicinal chemistry20030901

Title: Synthesis and dopamine receptor modulating activity of 3-substituted gamma-lactam peptidomimetics of L-prolyl-L-leucyl-glycinamide.

Journal: Journal of medicinal chemistry20030227

Building Blocks More >
1216792-30-1
1216792-30-1
4-Methyl-5-(1-methylethoxy)-9H-pyrido[3,4-b]indole-3-carboxylicacidethylesterhydrochloride
AA01ENNG | MFCD08703090
489416-12-8
489416-12-8
ST-193
AA01ENTB | MFCD03296554
1825352-65-5
1825352-65-5
Risdiplam
AA01EO12 | MFCD31657372
1442472-39-0
1442472-39-0
Ripretinib
AA01EO4S | MFCD31657437
560083-42-3
560083-42-3
AC260584
AA01EO9C | MFCD30533365
835904-51-3
835904-51-3
Synta66
AA01EOFQ | MFCD30719243
1392278-76-0
1392278-76-0
iRGD peptide
AA01EOLL | MFCD31657451
1621884-22-7
1621884-22-7
PSI-7409 tetrasodium
AA01EOQ1 | MFCD31657447
1445578-25-5
1445578-25-5
(1-(5-chloropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone
AA01EOZ5
946572-73-2
946572-73-2
8-methyl-6E-nonenoicacid3-(4-hydroxy-3-methoxyphenyl)-2E-propen-1-ylester
AA01EP9P
Submit
© 2017 AA BLOCKS, INC. All rights reserved.